Jianning Yang
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 16
- Chronic Lymphocytic Leukemia Research 16
-
- Advanced Breast Cancer Therapies 5
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Rod Humerickhouse (13 shared papers)Sari H. Enschede (12 shared papers)John F. Seymour (10 shared papers)Andrew W. Roberts (10 shared papers)Hao Xiong (4 shared papers)Todd Busman (10 shared papers)Brad S. Kahl (8 shared papers)Peter Noertersheuser (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (6 papers)Clinical Pharmacology & Therapeutics (3 papers)Investigational New Drugs (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Jianning Yang
27 papers receiving 688 citations
Peers
Comparison fields: 5 of 64
- Genetics 254
- Pathology and Forensic Medicine 237
- Hematology 102
- Oncology 220
- Aging 12
Countries citing papers authored by Jianning Yang
This map shows the geographic impact of Jianning Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianning Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianning Yang more than expected).
Fields of papers citing papers by Jianning Yang
This network shows the impact of papers produced by Jianning Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianning Yang. The network helps show where Jianning Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianning Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 118 | |
| 2 | 2015 | 79 | |
| 3 | 2014 | 75 | |
| 4 | 2014 | 59 | |
| 5 | 2014 | 46 | |
| 6 | 2014 | 43 | |
| 7 | 2013 | 42 | |
| 8 | 2014 | 38 | |
| 9 | 2012 | 28 | |
| 10 | 2015 | 26 | |
| 11 | 2013 | 20 | |
| 12 | 2021 | 20 | |
| 13 | 2011 | 18 | |
| 14 | 2014 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2023 | 12 | |
| 17 | 2013 | 10 | |
| 18 | 2024 | 6 | |
| 19 | 2010 | 6 | |
| 20 | 2025 | 5 |
About Jianning Yang
Jianning Yang is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 29 papers that have together received 693 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Genetics (254 citations), Pathology and Forensic Medicine (237 citations), Hematology (102 citations), Oncology (220 citations) and Aging (12 citations). Jianning Yang has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Rod Humerickhouse, Sari H. Enschede, John F. Seymour, Andrew W. Roberts, Hao Xiong, Todd Busman, Brad S. Kahl, Peter Noertersheuser, Walid M. Awni and Sven Mensing. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Pharmacology & Therapeutics, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.